BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30267300)

  • 1. Comparative Modeling and Evaluation of Leukotriene B4 Receptors for Selective Drug Discovery Towards the Treatment of Inflammatory Diseases.
    Ibrahim MAA; Hassan AMA
    Protein J; 2018 Dec; 37(6):518-530. PubMed ID: 30267300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in function and structure of two leukotriene B
    Nakamura M; Shimizu T
    Biochem Pharmacol; 2022 Sep; 203():115178. PubMed ID: 35850310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
    Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
    Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative Computational Modeling of Agonist Binding to the Leukotriene Receptors BLT1 and BLT2].
    Kurakin GF; Lopina NP; Bordina GE
    Mol Biol (Mosk); 2020; 54(2):341-352. PubMed ID: 32392205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.
    Lundeen KA; Sun B; Karlsson L; Fourie AM
    J Immunol; 2006 Sep; 177(5):3439-47. PubMed ID: 16920986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage LTB
    Zhang Y; Olson RM; Brown CR
    J Lipid Res; 2017 Mar; 58(3):494-503. PubMed ID: 28053185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic target of leukotriene B
    Nakamura M; Shimizu T
    Biochimie; 2023 Dec; 215():60-68. PubMed ID: 37423557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene B4 receptors.
    Toda A; Yokomizo T; Shimizu T
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():575-85. PubMed ID: 12432944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice.
    Shao WH; Del Prete A; Bock CB; Haribabu B
    J Immunol; 2006 May; 176(10):6254-61. PubMed ID: 16670336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLT1 and BLT2: the leukotriene B(4) receptors.
    Tager AM; Luster AD
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):123-34. PubMed ID: 12895595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Contribution of BLT1 and BLT2 to Leukotriene B4-Induced Human NK Cell Cytotoxicity and Migration.
    Wang M; Mostafa El-Maghraby N; Turcotte S; Rola-Pleszczynski M; Stankova J
    Mediators Inflamm; 2015; 2015():389849. PubMed ID: 26696753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4.
    Qiu H; Johansson AS; Sjöström M; Wan M; Schröder O; Palmblad J; Haeggström JZ
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6913-8. PubMed ID: 16624877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct leukotriene B4 receptors, BLT1 and BLT2.
    Yokomizo T
    J Biochem; 2015 Feb; 157(2):65-71. PubMed ID: 25480980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukotriene B
    Yokomizo T; Shimizu T
    Immunol Rev; 2023 Aug; 317(1):30-41. PubMed ID: 36908237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.
    Zinn S; Sisignano M; Kern K; Pierre S; Tunaru S; Jordan H; Suo J; Treutlein EM; Angioni C; Ferreiros N; Leffler A; DeBruin N; Offermanns S; Geisslinger G; Scholich K
    J Biol Chem; 2017 Apr; 292(15):6123-6134. PubMed ID: 28242764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4 receptors: novel roles in immunological regulations.
    Yokomizo T
    Adv Enzyme Regul; 2011; 51(1):59-64. PubMed ID: 21035496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung.
    Watanabe M; Machida K; Inoue H
    Expert Rev Respir Med; 2014 Aug; 8(4):381-3. PubMed ID: 24742066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.
    Yokomizo T; Kato K; Terawaki K; Izumi T; Shimizu T
    J Exp Med; 2000 Aug; 192(3):421-32. PubMed ID: 10934230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel computational methodologies for structural modeling of spacious ligand binding sites of G-protein-coupled receptors: development and application to human leukotriene B4 receptor.
    Ishino Y; Harada T
    ScientificWorldJournal; 2012; 2012():691579. PubMed ID: 23304088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases.
    Park H; Harmalkar DS; Wei JD; Sun S; Kwon J; Lee CH; Song JG; Park JM; Lee JW; Ahn KS; Han HK; Kim JH; Lee K; Choi Y
    Eur J Med Chem; 2023 Dec; 261():115864. PubMed ID: 37839347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.